| Product Code: ETC6751330 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Postmenopausal Vaginal Atrophy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 China Postmenopausal Vaginal Atrophy Market - Industry Life Cycle |
3.4 China Postmenopausal Vaginal Atrophy Market - Porter's Five Forces |
3.5 China Postmenopausal Vaginal Atrophy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Postmenopausal Vaginal Atrophy Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.7 China Postmenopausal Vaginal Atrophy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Postmenopausal Vaginal Atrophy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China Postmenopausal Vaginal Atrophy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Postmenopausal Vaginal Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about postmenopausal vaginal atrophy (PVA) and its impact on women's health |
4.2.2 Growing elderly population in China leading to a larger target demographic |
4.2.3 Rising healthcare expenditure and focus on women's health issues |
4.3 Market Restraints |
4.3.1 Stigma and cultural barriers related to discussing women's intimate health concerns |
4.3.2 Limited access to healthcare services in rural areas impacting diagnosis and treatment of PVA |
4.3.3 Lack of specialized healthcare professionals knowledgeable about PVA |
5 China Postmenopausal Vaginal Atrophy Market Trends |
6 China Postmenopausal Vaginal Atrophy Market, By Types |
6.1 China Postmenopausal Vaginal Atrophy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Estrogen based drugs, 2021- 2031F |
6.1.4 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Non-estrogen based drugs, 2021- 2031F |
6.1.5 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Postmenopausal Vaginal Atrophy Market, By Drug Form |
6.2.1 Overview and Analysis |
6.2.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Vaginal gel, 2021- 2031F |
6.2.3 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.4 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2.5 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Postmenopausal Vaginal Atrophy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Intravaginal, 2021- 2031F |
6.3.4 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Postmenopausal Vaginal Atrophy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Postmenopausal Vaginal Atrophy Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 China Postmenopausal Vaginal Atrophy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Postmenopausal Vaginal Atrophy Market Import-Export Trade Statistics |
7.1 China Postmenopausal Vaginal Atrophy Market Export to Major Countries |
7.2 China Postmenopausal Vaginal Atrophy Market Imports from Major Countries |
8 China Postmenopausal Vaginal Atrophy Market Key Performance Indicators |
8.1 Number of educational campaigns or events focused on PVA awareness |
8.2 Percentage increase in prescriptions of PVA treatment options |
8.3 Number of healthcare facilities offering specialized services for PVA |
8.4 Average age of women diagnosed with PVA |
8.5 Number of research studies conducted on PVA in China |
9 China Postmenopausal Vaginal Atrophy Market - Opportunity Assessment |
9.1 China Postmenopausal Vaginal Atrophy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Postmenopausal Vaginal Atrophy Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.3 China Postmenopausal Vaginal Atrophy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Postmenopausal Vaginal Atrophy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China Postmenopausal Vaginal Atrophy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Postmenopausal Vaginal Atrophy Market - Competitive Landscape |
10.1 China Postmenopausal Vaginal Atrophy Market Revenue Share, By Companies, 2024 |
10.2 China Postmenopausal Vaginal Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here